Areas of controversy in neuroprogression in bipolar disorder
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Objective: We aimed to review clinical features and biological underpinnings related to neuroprogression in bipolar disorder (BD). Also, we discussed areas of controversy and future research in the field. Method: We systematically reviewed the extant literature pertaining to neuroprogression and BD by searching PubMed and EMBASE for articles published up to March 2016. Results: A total of 114 studies were included. Neuroimaging and clinical evidence from cross‐sectional and longitudinal studies show that a subset of patients with BD presents a neuroprogressive course with brain changes and unfavorable outcomes. Risk factors associated with these unfavorable outcomes are number of mood episodes, early trauma, and psychiatric and clinical comorbidity. Conclusion: Illness trajectories are largely variable, and illness progression is not a general rule in BD. The number of manic episodes seems to be the clinical marker more robustly associated with neuroprogression in BD. However, the majority of the evidence came from cross‐sectional studies that are prone to bias. Longitudinal studies may help to identify signatures of neuroprogression and integrate findings from the field of neuroimaging, neurocognition, and biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Self-citationRelapse and impairment in bipolar disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1635 · Cited by 762
Absolute Risk of Suicide After First Hospital Contact in Mental Disorder
Nordentoft, M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.113 · Cited by 689
Comorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677 · cited 1×
“Notably, patients with BD are at higher risk of premature death from cardiovascular disease, diabetes, COPD, influenza, or pneumonia as compared to the general population (56).”
BackgroundThe role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594
Self-citationNeurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
Xanthos, D. N., & Sandkühler, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3617 · Cited by 580
Scott, J., Paykel, E., Morriss, R., Bentall, R., Kinderman, P., Johnson, T., Abbott, R., & Hayhurst, H. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.313 · Cited by 566
Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study
MacCabe, J. H., Lambe, M. P., Cnattingius, S., Sham, P. C., David, A. S., Reichenberg, A., Murray, R. M., & Hultman, C. M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.060368 · Cited by 345 · cited 1×
“Notably, neurocognitive changes, albeit potentially less marked, are evident after the first episode of mania (69), which stands in contrast to at-risk studies, where individuals who transition into BD may display superior neurocognition (70).”
ResultBora, E., & Pantelis, C. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu198 · Cited by 341 · cited 1×
“Another recent meta-analysis found that neurocognitive dysfunction in first-episode BD was comparable to that of more chronic cases of BD (76).”
ResultGrey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies
Selvaraj, S., Arnone, D., Job, D., Stanfield, A., Farrow, T. F., Nugent, A. C., Scherk, H., Gruber, O., Chen, X., Sachdev, P. S., et al. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01000.x · Cited by 341
Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study
Torrent, C., Bonnin, C. D. M., Martínez-Arán, A., Valle, J., Amann, B. L., González-Pinto, A., Crespo, J. M., Ibáñez, Á., Garcia-Portilla, M. P., Tabarés-Seisdedos, R., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070971 · Cited by 330 · cited 1×
“significant efficacy in improving functional impairment in patients with BD (92).”
BackgroundSelf-citationKapczinski, F., Magalhães, P. V. S., Balanzá‐Martinez, V., Dias, V. V., Frangou, S., Gama, C. S., Gonzalez‐Pinto, A., Grande, I., Ha, K., Kauer‐Sant'Anna, M., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12305 · Cited by 217
Self-citationLong-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres
Martinsson, L., Wei, Y., Xu, D., Melas, P. A., Mathé, A. A., Schalling, M., Lavebratt, C., & Backlund, L. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.37 · Cited by 179 · cited 1×
“Of note, long-term lithium treatment in BD is associated with longer leukocyte telomeres (129, 130).”
BackgroundRegenold, W. T., Phatak, P., Marano, C. M., Gearhart, L., Viens, C. H., & Hisley, K. C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.019 · Cited by 178 · cited 1×
“Specifically, postmortem studies report reductions in neuronal density in individual cortical layers (96, 97), lower glial cell count and density, and a decrease in the number of oligodendrocytes in different brain regions (97, 98), which is in accordance with reports of reduced myelin staining in brains of bipolar pa…”
ResultOne‐year psychosocial functioning in patients in the early vs. late stage of bipolar disorder
Rosa, A. R., González‐Ortega, I., González‐Pinto, A., Echeburúa, E., Comes, M., Martínez‐Àran, A., Ugarte, A., Fernández, M., & Vieta, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01830.x · Cited by 166
Self-citationComorbid medical illness in bipolar disorder
Forty, L., Ulanova, A., Jones, L., Jones, I., Gordon-Smith, K., Fraser, C., Farmer, A., McGuffin, P., Lewis, C. M., Hosang, G. M., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.152249 · Cited by 166 · cited 2×
“A recent study compared 440 patients with BD and three or more medical illnesses with 202 patients with BD and no history of medical illness (54).”
BackgroundMunkholm, K., Vinberg, M., & Kessing, L. V. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.54 · Cited by 157 · cited 3×
“However, conflicting results have been published using different populations (123, 124), and a recent metaregression study actually suggested that longer illness duration was associated with higher BDNF levels in patients with BD (125).”
BackgroundResultElvsåshagen, T., Vera, E., Bøen, E., Bratlie, J., Andreassen, O. A., Josefsen, D., Malt, U. F., Blasco, M. A., & Boye, B. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.006 · Cited by 133
A five‐year follow‐up study of neurocognitive functioning in bipolar disorder
Santos, J. L., Aparicio, A., Bagney, A., Sánchez‐Morla, E. M., Rodríguez‐Jiménez, R., Mateo, J., & Jiménez‐Arriero, M. Á. (2014) · Bipolar Disorders · doi:10.1111/bdi.12215 · Cited by 93
Gildengers, A. G., Chisholm, D., Butters, M. A., Anderson, S. J., Begley, A., Holm, M., Rogers, J. C., Reynolds, C. F., & Mulsant, B. H. (2013) · Psychological Medicine · doi:10.1017/s0033291712001614 · Cited by 89
Gignac, A., McGirr, A., Lam, R. W., & Yatham, L. N. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09245 · Cited by 71
Predictors of excellent response to lithium: results from a nationwide register-based study
Kessing, L. V., Hellmund, G., & Andersen, P. K. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834a5cd0 · Cited by 68
Tobacco use in bipolar disorder
Thomson, D., Berk, M., Dodd, S., Rapado-Castro, M., Quirk, S. E., Ellegaard, P. K., Berk, L., & Dean, O. M. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.1 · Cited by 63
Self-citationKozicky, J.-M., Torres, I. J., Silveira, L. E., Bond, D. J., Lam, R. W., & Yatham, L. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08928 · Cited by 52
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“The progressive course of illness in patients with multiple episodes is called clinical progression and the biological basis of clinical progression is defined as neuroprogression (28, 29).”
BackgroundSelf-citationVieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Self-citationCarvalho, A. F., Firth, J., & Vieta, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1906193 · Cited by 562
Self-citationEarly Intervention in Bipolar Disorder
Vieta, E., Salagre, E., Grande, I., Carvalho, A. F., Fernandes, B. S., Berk, M., Birmaher, B., Tohen, M., & Suppes, T. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17090972 · Cited by 354
Self-citationCognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
Solé, B., Jiménez, E., Torrent, C., Reinares, M., Bonnin, C. D. M., Torres, I., Varo, C., Grande, I., Valls, E., Salagre, E., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx032 · Cited by 299
Self-citation
Metadata
- Authors
- Passos, I. C., Mwangi, B., Vieta, E., Berk, M., & Kapczinski, F.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2016-04-21
- Volume
- 134
- Issue
- 2
- Pages
- 91-103
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2335867914
- Cited by
- 208
- References
- 27
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.